| Concord Biotech Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 543960 |
NSE Symbol : CONCORDBIO |
P/E(TTM) : 75.12 |
|
ISIN Demat : INE338H01029 |
Div & Yield% : 0.39 |
EPS(TTM) : 30.06 |
|
Book Value(₹) : 145.80 |
Market Cap(₹Cr) : 23,624.43 |
Face Value(₹) : 1.00 |
| Particulars | Mar '24 | Mar '23 | Mar '22 | Mar '21 | Mar '20 |
|---|---|---|---|---|---|
| INCOME : | |||||
| Sales Turnover | 1,016.94 | 853.17 | 712.93 | 616.94 | 512.33 |
| Excise Duty | - | - | - | - | - |
| Net Sales | 1,016.94 | 853.17 | 712.93 | 616.94 | 512.33 |
| Other Income | 33.78 | 35.31 | 23.42 | 13.81 | 31.37 |
| Stock Adjustments | 12.08 | 15.63 | 23.98 | 39.05 | 4.85 |
| Total Income | 1,062.80 | 904.11 | 760.33 | 669.80 | 548.55 |
| EXPENDITURE : | |||||
| Raw Materials | 241.28 | 195.84 | 187.99 | 150.61 | 134.79 |
| Power and Fuel Cost | 104.97 | 97.65 | 71.64 | 39.86 | 37.30 |
| Other Manufacturing Expenses | 28.00 | 24.93 | 17.10 | 12.99 | 30.93 |
| Selling and Administration Expenses | 91.08 | 82.93 | 67.90 | 44.87 | 31.74 |
| Miscellaneous Expenses | 8.46 | 13.20 | 22.66 | 10.26 | 15.65 |
| Employee Benefit Expenses | 123.05 | 110.28 | 95.69 | 69.47 | 62.24 |
| Less: Preoperative Expenditure | - | - | - | - | - |
| Total Expenses | - | - | - | - | - |
| Operating Profit | 465.97 | 379.27 | 297.34 | 341.74 | 235.91 |
| Interest | 3.18 | 5.18 | 6.13 | 1.05 | 1.17 |
| Gross Profit | 462.79 | 374.09 | 291.21 | 340.69 | 234.74 |
| Depreciation | 53.59 | 54.03 | 50.05 | 27.52 | 21.25 |
| Profit Before Tax | 409.20 | 320.06 | 241.16 | 313.17 | 213.49 |
| Current Tax | 99.83 | 79.53 | 58.49 | 75.72 | 54.53 |
| Fringe Benefit tax | - | - | - | - | - |
| Deferred Tax | 4.63 | 2.40 | 4.10 | 2.11 | -10.00 |
| Reported Net Profit | 304.73 | 238.13 | 178.57 | 235.33 | 168.96 |
| Extraordinary Items | 10.48 | 2.70 | 3.86 | 5.24 | 17.47 |
| Adjusted Net Profit | 294.25 | 235.43 | 174.71 | 230.09 | 151.49 |
| Adjustment below Net Profit | -0.01 | 0.26 | -0.56 | -0.04 | -0.84 |
| Profit/Loss Balance carried down | 1,170.33 | 985.51 | 878.02 | 648.43 | 560.85 |
| Statutory Appropriations | - | - | - | - | - |
| Appropriations | 71.45 | 53.56 | 70.52 | 5.71 | 80.55 |
| P & L Balance carried down | 1,403.60 | 1,170.33 | 985.51 | 878.02 | 648.43 |
| Dividend | - | - | - | - | - |
| Preference Dividend | - | - | - | - | - |
| Equity Dividend (%) | 875.00 | 683.00 | 51.20 | - | 392.50 |
| Dividend Per Share(Rs) | 8.75 | 6.83 | 5.12 | - | 39.25 |
| Earnings Per Share-Unit Curr | 29.13 | 22.76 | 187.76 | 247.44 | 177.66 |
| Earnings Per Share(Adj)-Unit Curr | 29.13 | - | - | - | - |
| Book Value | 145.80 | 123.50 | 1,164.13 | 1,051.11 | 809.71 |
| Book Value(Adj)-Unit Curr | 145.80 | - | - | - | - |